Inhibiting PKM2 activation reduced IL-1β release and improved survival in septic mice while promoting PKM2 activation increased IL-1β levels and significantly reduced the host immune response in a sepsis model (Yang et al., 2014; Palsson-McDermott et al., 2015a). The gene discussed is PKM; the disease is Sepsis.